# Synthetic Biology: At the Crossroads of Genetic Engineering and Human Therapeutics

> **NIH NIH R13** · KEYSTONE SYMPOSIA · 2020 · $10,000

## Abstract

Abstract
Support is requested for a Keystone Symposia conference entitled Synthetic Biology: At the Crossroads of
Genetic Engineering and Human Therapeutics, organized by Drs. Jose M. Lora and Timothy K. Lu. The
conference will be held in Breckenridge, Colorado from March 29- April 1, 2019.
Synthetic Biology tools and principles have matured tremendously over the last decade and have reached
extraordinary levels of sophistication, both in eukaryotic and prokaryotic systems. Synthetic biology as a
therapeutic modality is starting to enter multiple clinical studies and has the potential to have a significant
impact on medicine across a wide range of diseases (e.g., metabolic, immune-mediated, cancer, and
neurologic diseases). This Keystone Symposia conference will delve into the field of synthetic biology with a
special emphasis on its applications to medicine. While there are conferences that capture synthetic biology in
only a few talks mixed in among other various topics, there is a paucity of conferences focused on synthetic
biology as drugs to treat disease. However, due to the rapid pace of fundamental scientific advances along
with an expanding number of biotechnology companies and emerging clinical studies with synthetic biology at
their core, this conference will be highly relevant for a wide audience of scientists both from academia and
industry. In addition, other meetings in this field have a highly technology-driven focus on synthetic biology
techniques with relatively little attention given to biological and medical context. Ultimately, this Keystone
Symposia conference should inspire researchers from diverse backgrounds to discuss synthetic biology via
many new angles.

## Key facts

- **NIH application ID:** 9913772
- **Project number:** 1R13EB029305-01
- **Recipient organization:** KEYSTONE SYMPOSIA
- **Principal Investigator:** Thale Cross Jarvis
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $10,000
- **Award type:** 1
- **Project period:** 2020-02-06 → 2022-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9913772

## Citation

> US National Institutes of Health, RePORTER application 9913772, Synthetic Biology: At the Crossroads of Genetic Engineering and Human Therapeutics (1R13EB029305-01). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9913772. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*